317 related articles for article (PubMed ID: 22426901)
1. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.
Chan VO; Das JP; Gerstenmaier JF; Geoghegan J; Gibney RG; Collins CD; Skehan SJ; Malone DE
Ir J Med Sci; 2012 Dec; 181(4):499-509. PubMed ID: 22426901
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
[TBL] [Abstract][Full Text] [Related]
3. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
[TBL] [Abstract][Full Text] [Related]
4. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
Mainenti PP; Mancini M; Mainolfi C; Camera L; Maurea S; Manchia A; Tanga M; Persico F; Addeo P; D'Antonio D; Speranza A; Bucci L; Persico G; Pace L; Salvatore M
Abdom Imaging; 2010 Oct; 35(5):511-21. PubMed ID: 19562412
[TBL] [Abstract][Full Text] [Related]
5. Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer.
Cho JY; Lee YJ; Han HS; Yoon YS; Kim J; Choi Y; Shin HK; Lee W
World J Surg; 2015 May; 39(5):1161-6. PubMed ID: 25609116
[TBL] [Abstract][Full Text] [Related]
6. Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis.
Tsili AC; Alexiou G; Naka C; Argyropoulou MI
Acta Radiol; 2021 Mar; 62(3):302-312. PubMed ID: 32506935
[TBL] [Abstract][Full Text] [Related]
7. Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference.
Berger-Kulemann V; Schima W; Baroud S; Koelblinger C; Kaczirek K; Gruenberger T; Schindl M; Maresch J; Weber M; Ba-Ssalamah A
Eur J Surg Oncol; 2012 Aug; 38(8):670-6. PubMed ID: 22652037
[TBL] [Abstract][Full Text] [Related]
8. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.
Scharitzer M; Ba-Ssalamah A; Ringl H; Kölblinger C; Grünberger T; Weber M; Schima W
Eur Radiol; 2013 Aug; 23(8):2187-96. PubMed ID: 23519439
[TBL] [Abstract][Full Text] [Related]
9. Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI.
Kim KA; Kim MJ; Choi JY; Park MS; Lim JS; Chung YE; Kim KW
Abdom Imaging; 2014 Apr; 39(2):291-9. PubMed ID: 24384804
[TBL] [Abstract][Full Text] [Related]
10. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
Kulemann V; Schima W; Tamandl D; Kaczirek K; Gruenberger T; Wrba F; Weber M; Ba-Ssalamah A
Eur J Radiol; 2011 Aug; 79(2):e1-6. PubMed ID: 20392584
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT.
Kim YK; Park G; Kim CS; Yu HC; Han YM
Br J Radiol; 2012 May; 85(1013):539-47. PubMed ID: 22556405
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
13. Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?
Sofue K; Tsurusaki M; Murakami T; Onoe S; Tokue H; Shibamoto K; Arai Y; Sugimura K
Eur Radiol; 2014 Oct; 24(10):2532-9. PubMed ID: 24865698
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E
Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846
[TBL] [Abstract][Full Text] [Related]
15. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.
Lee KH; Lee JM; Park JH; Kim JH; Park HS; Yu MH; Yoon JH; Han JK; Choi BI
Korean J Radiol; 2013; 14(6):894-904. PubMed ID: 24265564
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH
J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148
[TBL] [Abstract][Full Text] [Related]
17. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
Lee DH; Lee JM; Hur BY; Joo I; Yi NJ; Suh KS; Kang KW; Han JK
Radiology; 2016 Sep; 280(3):782-92. PubMed ID: 27092659
[TBL] [Abstract][Full Text] [Related]
18. Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study.
Görgec B; Hansen I; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bisschops RHC; Bollen TL; Bosscha K; Burgmans MC; Cappendijk V; De Boer MT; D'Hondt M; Edwin B; Gielkens H; Grünhagen DJ; Gillardin P; Gobardhan PD; Hartgrink HH; Horsthuis K; Kok NFM; Kint PAM; Kruimer JWH; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Morone M; Pennings JP; Peringa J; Te Riele WW; Vermaas M; Wicherts D; Willemssen FEJA; Zonderhuis BM; Bossuyt PMM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J;
BMC Cancer; 2021 Oct; 21(1):1116. PubMed ID: 34663243
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE
Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057
[TBL] [Abstract][Full Text] [Related]
20. Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation.
Böttcher J; Hansch A; Pfeil A; Schmidt P; Malich A; Schneeweiss A; Maurer MH; Streitparth F; Teichgräber UK; Renz DM
Eur J Radiol; 2013 Nov; 82(11):1860-9. PubMed ID: 23932636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
